← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aviara Pharmaceuticals, Inc.
Houston, TX
$2,293,047
Total funding
2
Grants
Funding over time
peak $1M · FY2020–24$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,293,047 · 2
By mechanism
R42$1,996,323 · 1
R41$296,724 · 1
Investigators at Aviara Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD$1,036,641
R42 · FY2023 · DK
Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD$959,682
R42 · FY2024 · DK
Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD$296,724
R41 · FY2020 · DK